(S)-3-(2,2-dimethyl-1,3-dioxolan-4-yl)propan-1-ol, 95%, 1g

4-Bromo-3-hydroxypyridine, 96.0%, 25g

(3-((2-Chloro-4-methylphenyl)carbamoyl)-5-fluorophenyl)boronic acid, 98%, 250mg

2-Amino-1-(4-(trifluoromethyl)phenyl)ethanonehydrochloride, 95.0%, 1g

(1-(4-Bromophenyl)cyclopropyl)methanol, 95.0%, 100mg

(S)-(+)-2-[Hydroxy(diphenyl)methyl]-1-methylpyrrolidine>98.0%(GC)1g

3,4-Dibromo-2-fluoroiodobenzene, 5g

tert-Butyl N-[1-(pyrimidin-4-yl)piperidin-4-yl]methylcarbamate, 1g

1-(2-pyrrolidinylmethyl)-1H-imidazole dihydrochloride, 95.0%, 250mg

6-Bromo-2-methylindole, 95.0%, 250mg

N,N'-Disuccinimidyl carbonate, 95.0%, 100g

Phase contrast Abbe condenser with slide for Plan PLPHi 20/S100 phase contrast infinity corrected objectives, slide with 20 and 100x phases, telescope and green filter

5-Bromo-2-methoxy-4-methylpyridin-3-amine, 98%, 5g